The GGH expression level was also a significant predictor of DSS for the clinical Stage I subgroup, the residual tumor R0 subgroup, and the CR subgroup, while high GGH expression had no prognostic value for PFI in any subgroup (Figure 4A). Here, GGH is linked to neoplasm.